相关实验视频

Updated: Jun 11, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

瘤性HSV-1载体诱导治疗适应性免疫反应对抗质母细胞瘤

Alberto Reale¹, Andrea Gatta², Amruth Kaleem Basha Shaik²

¹Department of Molecular Medicine, University of Padua, Padua, 35131, Italy.

Journal of translational medicine

|September 28, 2024

概括

瘤性简单性疹病毒1型 (oHSV-1) 有效地准质母细胞瘤 (GBM) 细胞,延长存活时间并诱导免疫反应. 这种疗法显示出强大的抗瘤活性,为对抗这种侵袭性脑瘤的临床应用铺平了道路.

科学领域:

瘤治疗性病毒疗法
免疫瘤学免疫瘤学
神经瘤学神经瘤学

背景情况:

质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
瘤病毒 (OV) 正在成为GBM的潜在治疗方法,因为它们具有选择性向癌症的能力.

研究的目的:

在一个免疫能力强的模型中,评估一种经过修改的瘤性简单疹病毒1型 (oHSV-1) 表达增强绿色光蛋白 (EGFP-oHSV-1) 对小鼠GL261质母细胞瘤 (GBM) 的疗效.
评估直接的抗瘤效应和诱导的免疫反应.

主要方法:

产生EGFP-oHSV-1与神经病毒性基因缺失的基因.
在GL261 GBM细胞系上进行体外试验.
在具有已确定的GL261瘤的小鼠中进行EGFP-oHSV-1的内注射.
瘤微环境和免疫细胞透的免疫组织化学分析.

主要成果:

证明EGFP-oHSV-1在体外复制并诱导GL261细胞死亡.
在所有接受治疗的小鼠中,单次内注射显著延长了生存时间.
45%的接受治疗的小鼠实现了长期存活,并拒绝了瘤的再发作,这表明了适应性免疫反应.
治疗导致CD4+和CD8+T细胞透增加,血管缩,骨髓和质细胞激活,纤维组织形成.

结论:

在免疫能力强的GBM模型中,EGFP-oHSV1表现出强大的单一疗法抗瘤活性.
疗效来自于直接杀死瘤细胞和刺激保护性自适应性免疫反应.
这一策略在GBM治疗中具有临床应用的前景.

关键词:

在GL261中,我们使用了GL261 质母细胞瘤 (glioblastoma) 是一个在HSV-1病毒中,免疫治疗是一种免疫疗法.瘤学病毒病毒.

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...